More articles from Thyroid and Para-Thyroid

You have access
¹⁸F-FCH PET/CT for patients with uremic hyperparathyroidism
Yu Xue

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 513;
You have access
Tc-99m DTPA orbital SPECT/CT guided Selection for riamcinolone Acetonide Injection in Patients with Thyroid Associated Ophthalmopathy
Chengzhi Jiang, Min Zhao, Jian Chen, Jin Huang, Yajie Zhao, Jinyan Liu, Miaomiao Liu, Haoyu Deng and Xinhui Li

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 507;
You have access
PET imaging of phosphodiesterase 4 in brain and peripheral organs of McCune-Albright syndrome
Lora Weidner, Michael Collins, Alison Boyce, Yuichi Wakabayashi, Louise Stolz, Lori Guthrie, Denise Rallis-Frutos, Sami Zoghbi, Victor Pike, Masahiro Fujita and Robert Innis

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 506;
You have access
99mTc-Tetrofosmin dual phase study for detection of parathyroid adenoma and comparison with 99mTcO4/99mTc-Tetrofosmin dual tracer technique
Khalid Makhdomi

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 514;
You have access
Post total thyroidectomy elevated anti-thyroglobulin antibodies in patients with differentiated thyroid cancer - Residual disease or residual thyroiditis?
Ashwin Parihar, Tinu Lukose, Ashwani Sood, Bhagwant Mittal and Anish Bhattacharya

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 509;
You have access
“Thyroid flare” phenomenon on FDG-PET/CT after radiotherapy for extranodal mucosa-associated lympoid tissue lymphoma in the thyroid.
Kunihiro Nakada, Keiichi Kamijo, Naoya Hattori, Hiroki Sugie, Noriyoshi Kato and Sakurai Masayuki

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 510;
You have access
BI-847325 suppressed both wild and vemurafenib-resistant thyroid carcinoma BCPAP cells via inhibition of MEK/ERK pathway
Pengyi Deng and Bangping Cui

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 511;
You have access
Can we improve the specificity of Parathyroid SPECT/CT scans by better pre test selection ?
Mark Tann, Joseph Thomas, Konstantin Gruenwald and Justin Sims

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 512;
You have access
Potassium iodide therapy may not impair efficacy of radioiodine therapy for Graves’ hyperthyroidism if discontinued 2 weeks before administration of I-131
MIka Tamura, Kunihiro Nakada, Katsuhiko Kato, Noriyoshi Kato, Tsunenori Mizukoshi and Sakurai Masayuki

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 508;

Main menu

User menu

Search

More articles from Thyroid and Para-Thyroid